ScanSource is undervalued at 27.00 per share with modest projections ahead. ScanSource has
performance score of 1 on a scale of 0 to 100. The entity has a beta of 0.1828, which indicates not very significant fluctuations relative to the market. Let's try to break down what ScanSource's beta means in this case. As returns on the market increase, ScanSource returns are expected to increase less than the market. However, during the bear market, the loss on holding ScanSource will be expected to be smaller as well. Although it is extremely important to respect
ScanSource current price movements, it is better to be realistic regarding the information on equity historical returns. The philosophy towards measuring
future performance of any stock is to evaluate the business as a whole together with its past performance, including all
available fundamental and
technical indicators. By inspecting
ScanSource technical indicators, you can presently evaluate if the expected return of 0.0505% will be sustainable into the future.
ScanSource right now has a risk of 2.93%. Please validate ScanSource
treynor ratio, and the
relationship between the
standard deviation and
downside variance to decide if ScanSource will be following its existing
price patterns.
The performance of ScanSource in the marketplace will significantly impact your decision to invest in its stock. Revenue growth, profitability, competitive positioning, management quality, and industry trends can influence ScanSource's
stock prices. When investing in ScanSource, there are several factors to consider and potential outcomes to expect. As a company performs well, its stock price may increase, allowing investors to benefit from price appreciation. However, ScanSource Stock can experience significant price fluctuations due to market conditions, economic factors, industry trends, or company-specific news. This is why investing in stocks such as ScanSource carries risks, including the potential for capital loss. Stock prices can decline, and investors may incur losses if they sell shares at a lower price than their initial investment.
How important is ScanSource's Liquidity
ScanSource
financial leverage refers to using borrowed capital as a funding source to finance ScanSource ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. ScanSource financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Financial leverage can amplify the potential profits to ScanSource's owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its debt costs. The degree of ScanSource's financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets). Please check the
breakdown between ScanSource's total debt and its cash.
ScanSource Gross Profit
ScanSource Gross Profit growth is one of the most critical measures in evaluating the company. The Gross Profit growth rate is calculated simply by comparing ScanSource previous period's values with its current period's values. Each time period you're measuring should be of equal lengths the increase or decrease, in a company's Gross Profit between two periods. Here we show ScanSource Gross Profit growth over the last 10 years. Please check ScanSource's
gross profit and other
fundamental indicators for more details.
Another Deeper Perspective
ScanSource shows a total of twenty-five million three hundred fifty thousand
outstanding shares. The majority of ScanSource
outstanding shares are owned by
institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in ScanSource to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in ScanSource. Please pay attention to any change in the institutional holdings of ScanSource as this could imply that something significant has changed or about to change at the company. Also note that roughly two hundred fifty-three thousand five hundred invesors are currently shorting ScanSource expressing very little confidence in its
future performance.
| 2019 | 2020 (projected) |
Consolidated Income | 57.26 M | 49.91 M | Direct Expenses | 3.08 B | 2.81 B |
Ownership Breakdown
| Retail Investors | -1.11 |
| Insiders | 2.02 |
| Institutions | 99.09 |
Over 3 percent rise for ScanSource. What does it mean for investors?
Current expected short fall indicator falls down to -1.8. Possible price jump? ScanSource shows above-average downside volatility for the selected time horizon. We advise investors to inspect ScanSource further and ensure that all market timing and asset allocation strategies are consistent with the estimation of ScanSource future alpha.
Our Final Take On ScanSource
Whereas other companies within the electronics & computer distribution industry are still a little expensive, even after the recent corrections, ScanSource may offer a potential longer-term growth to investors. The inconsistency in the assessment between current ScanSource valuation and our trade advice on ScanSource is due to the recent market swings and your selection of investing horizon. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to ScanSource.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
Ellen Johnson is a Member of Macroaxis Editorial Board. Ellen covers public companies in North America, focusing primarily on valuation and volatility. Six years of experience in predictive investment analytics and risk management.
View Profile This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Ellen Johnson do not own shares of ScanSource. Please refer to our
Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to
editors@macroaxis.com